pazopanib adalvo 200 mg filmom obalené tablety
adalvo limited, malta - pazopanib - 44 - cytostatica
gavreto
roche registration gmbh - pralsetinib - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
pazopanib teva 400 mg filmom obalené tablety
teva b.v., holandsko - pazopanib - 44 - cytostatica
pazopanib teva 200 mg filmom obalené tablety
teva b.v., holandsko - pazopanib - 44 - cytostatica
pazopanib zentiva 400 mg
zentiva k.s., Česká republika - pazopanib - 44 - cytostatica
pazopanib zentiva 200 mg
zentiva k.s., Česká republika - pazopanib - 44 - cytostatica
pazopanib stada 400 mg
stada arzneimittel ag, nemecko - pazopanib - 44 - cytostatica
pazopanib stada 200 mg
stada arzneimittel ag, nemecko - pazopanib - 44 - cytostatica
pazopanib glenmark 400 mg filmom obalené tablety
glenmark pharmaceuticals s.r.o., Česká republika - pazopanib - 44 - cytostatica
pazopanib glenmark 200 mg filmom obalené tablety
glenmark pharmaceuticals s.r.o., Česká republika - pazopanib - 44 - cytostatica